TFRC and cancer: But the results are not overly convincing with very mild changes evident when cisplatin-induced toxicity was “reversed.” Another study reports that cisplatin depletes cancer cells of iron by directly binding to IRP2, inhibiting its binding to IREs and as a result increased ferritin and decreased TfR1 expression, thus lowering the LIP (257).